Dupilumab and mepolizumab are the only FDA-approved biologics for adults with COPD and an eosinophilic phenotype. Mepolizumab has been assessed in patients with a blood eosinophil count of at least ...

Researchers looked at lung tissue from 28 COPD patients and 15 smokers who underwent surgery for suspected or confirmed lung ...

Panelists discuss how riociguat targets the nitric oxide pathway and is approved for both Group 1 PAH and Group 4 chronic ...

Sanjay Ramakrishnan, MD, senior lecturer, University of Western Australia, breaks down how to communicate the value of ...

Among patients with COPD and type 2 inflammation, investigator-reported emphysema did not change benefits seen with dupilumab ...

COPD patients who receive intensive guidance from a hospital pharmacist during their stay use their inhalation medication ...

Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

Quantitative CT textures may provide imaging evidence of the spatial heterogeneity of lung inflammation and disease burden in COPD.

Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

The deep cuts to Medicaid outlined in President Trump’s budget reconciliation bill would hurt Americans suffering from conditions like chronic obstructive pulmonary disease (COPD), Rep. Maxine ...